about
Clinical utility of high-flow nasal cannula oxygen therapy for acute respiratory failure in patients with hematological diseaseFecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut.Retrospective analysis of clinical outcomes of the patients with chronic myeloid leukemia who stopped administration of tyrosine kinase inhibitors: a single institution experience.Central Nervous System Involvement at the Time of Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with a Poor Outcome in Patients with Acute Myeloid Leukemia.Donor cell leukemia with bone marrow necrosis.Disseminated nocardiosis after unrelated bone marrow transplantation.Chronic myeloid leukemia relapsing ten years after allogenic bone marrow transplantation.[Chronic myelogenous leukemia initially presenting with multiple subcutaneous tumors due to extramedullary hematopoiesis].Occurrence of Donor Cell-derived Lymphoid Blast Crisis 24 Years Following Related Bone Marrow Transplantation for Chronic Myeloid Leukemia.Optic neuritis as an initial manifestation of human herpesvirus 6 reactivation after unrelated bone marrow transplantation.CD25 expression on residual leukemic blasts at the time of allogeneic hematopoietic stem cell transplant predicts relapse in patients with acute myeloid leukemia without complete remission.Allogeneic hematopoietic stem cell transplant overcomes poor prognosis of acute myeloid leukemia with myelodysplasia-related changes.Erythrocytosis after allogeneic hematopoietic stem cell transplantation.Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Toxic encephalopathy after exposure to azacitidineLow incidence of thromboembolism in multiple myeloma patients receiving immunomodulatory drugs; a retrospective single-institution analysis[Transfusion-associated circulatory overload with pulmonary alveolar hemorrhage following allogeneic bone marrow transplantation]T315I mutation with lymphoblasts in a newly diagnosed patient with chronic-phase chronic myeloid leukemiaRemarkable donor-derived T cell lymphocytosis before engraftment of a bone marrow transplant for acute lymphoblastic leukemiaSuppressive effects of anagrelide on cell cycle progression and the maturation of megakaryocyte progenitor cell lines in human induced pluripotent stem cells
P50
Q36828700-4AB69C04-7DE4-4FE2-B41E-9204428C29F2Q37376599-2E224F44-C524-4A03-933F-15DF0FBEA680Q40371026-A763D3B1-930F-46D2-B653-733D4AF3954EQ40399440-35C61650-EC5C-4B53-9ABC-EEACB4B8D125Q40414162-BA1AA9B8-0A8F-414F-9065-9C7B4E721225Q40518943-2094390E-D36B-481C-B976-5E089AD92739Q40644980-3C93E6BE-138D-49FB-9AA7-BB20EBA7B068Q40678595-20BB433A-1DCB-40B7-8C70-90413C1386B9Q40791833-6E34A8FE-4541-4417-8A25-802E954A680DQ40926932-AECB4D97-9BA4-443F-B584-37BDEB1E45DEQ40973515-DC89F9AA-D298-4D2E-8FA5-D32FC82F680FQ41154840-58924020-86CE-4F00-8FBC-7D2943520F76Q44174784-089FB2AF-17FE-4110-8DFB-910B395AA465Q52842045-EF8FDC21-A3EF-40E3-8456-4727B89CCB76Q85316776-83C4B6F4-CD02-4ECB-A6EC-21B60B370F02Q91183062-39DD1DD0-2134-4F77-90A4-10FD1AE6D443Q91864245-DD0F5993-B33B-41FA-87E3-9634E78CB391Q92509402-45D6A3AC-693F-428E-84CF-99345D1C114DQ93115940-B0A95F6D-3193-40A4-BCAB-0C1C6DB47738Q93131799-30C3A8A4-753F-419D-8A99-6BEB4AA64FAB
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Yutaro Hino
@en
Yutaro Hino
@nl
type
label
Yutaro Hino
@en
Yutaro Hino
@nl
prefLabel
Yutaro Hino
@en
Yutaro Hino
@nl
P108
P31
P496
0000-0001-6938-6130